BreakThrough T1D/ADS Joint Symposium - Every stage and age of T1D: problem - challenge - solution
Tracks
Breakout 1: Arena 1
Wednesday, August 20, 2025 |
4:00 PM - 6:00 PM |
Arena 1 |
Speaker
Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d
Breakthrough T1D’s Research Vision over the next five years
4:00 PM - 4:10 PMBiography
Prof Jenny Couper
Head , Discipline of Paediatrics, University of Adelaide
Women's and Children's Hospital
Delivering optimal care of early type 1 diabetes in Australia
4:10 PM - 4:32 PMBiography
Jenny Couper is a clinician researcher and paediatric endocrinologist. She is Head of the Discipline of Paediatrics, University of Adelaide and was Head of the Diabetes and Endocrinology Department, Women’s and Children’s Hospital, SA. She leads the Australian early life at-risk cohort (ENDIA study www.endia.org.au) and the Breakthrough T1D Australian monitoring program of children with early type 1 diabetes. She co-chairs the ISPAD early type 1` diabetes advisory group and is a co –author of international guidelines for the management of type 1 diabetes in children and adolescents.
Prof John Wentworth
Endocrinologist and Senior Clinical Research Fellow
Royal Melbourne Hospital and St Vincent's Institute
Active and Emerging Immune Therapy Targets
4:32 PM - 4:54 PMBiography
Prof Thomas Kay
Director
St Vincent's Institute of Medical Research
Immunological barriers to cell therapy in type 1 diabetes, lessons from clinical trials and autoimmunity research
4:54 PM - 5:16 PMBiography
Prof Toby Coates
Director Of Transplantation
Royal Adelaide Hospital
Delivering beta cell therapies, innovations in transplantation
5:16 PM - 5:38 PMBiography
P. Toby Coates MD PhD is the Director of Kidney, Pancreas and Islet Transplantation at the Royal Adelaide Hospital and Professor at the University of Adelaide. He is a translational clinician scientist and transplant nephrologist. He was a foundation member of the Australian Islet Consortium in 2006. In 2017 his team undertook Australia’s first paediatric total pancreatectomy and islet auto transplant (TP-IAT) for Hereditary Pancreatitis in Adelaide. He founded Beta Cell Technologies for the development of alternative sites for islet cell transplantation. He is the principal investigator in the HEPATA study (Hereditary Pancreatitis and Islet Auto Transplantation Trials in Australia).
Dr Jennifer Snaith
Endocrinologist
Garvan Institute of Medical Research
Role of Adjunct Therapies in Type 1 Diabetes Management
5:38 PM - 6:00 PMBiography
Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d
Close
6:00 PM - 6:00 PMBiography
Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d
Chairperson
Biography
